MMP9 and melanoma: It will particularly focus on Matrix Metalloproteinase 9 (MMP-9), in the degradation of ECM and the consequent progression of melanoma, as well as the potential therapeutic implication of both endogenous and exogenous MMP inhibitors for the design of new therapeutic protocols for melanoma patients.